The Healthy Participant Research Study

The study will evaluate the safety of the study drug (an unapproved new drug) in humans. It will also evaluate what the body does to this study drug in healthy people. This potential new drug is being developed as a targeted therapy to treat patients with cancers that have a high number of specific mutations {microsatellite instability-high (MSI-H) or deficient in mismatch repair (dMMR) cancers}. This means that cancer cells accumulate a lot of errors (or mutations) in certain parts of the DNA and as a result, these cancers behave differently than other types of normal cells and other cancers.

Call us on 1800 243 733 to discuss your eligibility today!